ACTR-38. A SINGLE CENTER STUDY: LONG-TERM OUTCOMES OF COMBINED CHEMORADIATION THERAPY WITH TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA IN KOREAN PATIENT

In newly diagnosed glioblastoma (GBM), Temozolomide (TMZ) during and after radiation therapy has become standard treatment. This study describes the long-term use and follow-up results of this therapy for GBM. From 2004 to 2013 in a single institute, 112 Korean patients with newly diagnosed GBM were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Go, Kyeong-O, Young Yang, Ha, Hwang, Kihwan, Ho Han, Jung, Soo Choi, Hyoung, Jung Kim, Yu, Woo Wee, Chan, Ah Kim, In, Choe, Gheeyoung, Kim, Chae-Yong
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2019
Schlagworte:
Adult Clinical Trials - Non-Immunologic
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847143/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.080
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge